Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19) Ivan Lopez-Mendez; Jorge Aquino-Matus; Sofia Murua-Beltrán Gall; Jose D. Prieto-Nava; Eva Juarez-Hernandez; Misael Uribe; Graciela Castro-Narro;

SARS-CoV-2 another kind of liver aggressor, how does it do that? Sonia A. Lozano-Sepulveda; Kame Galan-Huerta; Natalia Martínez-Acuña; Daniel Arellanos-Soto; Ana María Rivas-Estilla;

Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies Alessio Gerussi; Daphne D¿Amato; Laura Cristoferi; Sarah Elizabeth O¿Donnell; Marco Carbone; Pietro Invernizzi;